The UW-Madison School of Medicine and Public Health is asking the American Medical Student Association to review and revise its PharmFree Scorecard, a report on conflict of interest policies, after UW got a D in the report.
“Our grade is not appropriate,” said Patrick McBride, associate dean for students. “We provided AMSA with the information, but they missed many critical details.”
The scorecard graded 150 medical schools around the country on conflict-of-interest policies such as accepting pharmaceutical samples or gifts, allowing drug company representatives to make their sales pitches or getting paid honoraria to speak about their products.